Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 12:23
Boundless Bio Price to Book Value : 0.8959 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.8925 |
| October 01, 2026 | 0.8823 |
| September 30, 2026 | 0.855 |
| September 29, 2026 | 0.8721 |
| September 28, 2026 | 0.8891 |
| September 25, 2026 | 0.9061 |
| September 24, 2026 | 0.8857 |
| September 23, 2026 | 0.9198 |
| September 22, 2026 | 0.9811 |
| September 21, 2026 | 0.9641 |
| September 18, 2026 | 0.9572 |
| September 17, 2026 | 0.9538 |
| September 16, 2026 | 0.9606 |
| September 15, 2026 | 0.9572 |
| September 14, 2026 | 0.9675 |
| September 11, 2026 | 0.9641 |
| September 10, 2026 | 0.9675 |
| September 09, 2026 | 0.9709 |
| September 08, 2026 | 0.9743 |
| September 04, 2026 | 0.9777 |
| September 03, 2026 | 0.9777 |
| September 02, 2026 | 0.9845 |
| September 01, 2026 | 0.9845 |
| August 31, 2026 | 0.9572 |
| August 28, 2026 | 0.9641 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.9743 |
| August 26, 2026 | 0.993 |
| August 25, 2026 | 1.002 |
| August 24, 2026 | 1.008 |
| August 21, 2026 | 1.022 |
| August 20, 2026 | 0.9879 |
| August 19, 2026 | 0.9743 |
| August 18, 2026 | 0.9743 |
| August 17, 2026 | 0.9641 |
| August 14, 2026 | 0.9641 |
| August 13, 2026 | 0.9453 |
| August 12, 2026 | 0.947 |
| August 11, 2026 | 0.9368 |
| August 10, 2026 | 0.9606 |
| August 07, 2026 | 0.9845 |
| August 06, 2026 | 0.9675 |
| August 05, 2026 | 0.9538 |
| August 04, 2026 | 0.9215 |
| August 03, 2026 | 0.8755 |
| July 31, 2026 | 0.8516 |
| July 30, 2026 | 0.8516 |
| July 29, 2026 | 0.8448 |
| July 28, 2026 | 0.8414 |
| July 27, 2026 | 0.8448 |
| July 24, 2026 | 0.8755 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.591 |
| Alnylam Pharmaceuticals, Inc. | 21.42 |
| Savara, Inc. | 6.849 |
| Vericel Corp. | 5.587 |
| Biogen, Inc. | 1.717 |
Price to Book Value Related Metrics
| Price | 2.63 |
| Earnings Yield | -108.6% |
| Market Cap | 59.11M |